P21 (Adamax) vs RG3 (Rhodiola)
Overview
P21 (Adamax) and RG3 (Rhodiola) are both cognitive enhancement peptides, but they differ in mechanism, dosing, and regulatory status.
This page compares P21 (Adamax) and RG3 (Rhodiola) across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.
Side-by-side comparison
| P21 (Adamax) | RG3 (Rhodiola) | |
|---|---|---|
| Category | Cognitive Enhancement | Cognitive Enhancement |
| Regulatory status (US) | Research use only | Research use only |
| Typical dosage | 5-20 mg | 3-6 mg |
| Frequency | intermittent | daily |
| Reported benefits | Enhanced learning, neuroplasticity, memory formation | Stress reduction, cognitive enhancement, energy |
| Reported side effects | Research compound, limited data | Well-tolerated |
Key differences
Primary use. P21 (Adamax) is categorised under Cognitive Enhancement, while RG3 (Rhodiola) falls under Cognitive Enhancement. Because they target a similar goal, they are common alternatives to weigh against each other.
Regulatory status. P21 (Adamax): not FDA-approved; treated as a research compound. RG3 (Rhodiola): not FDA-approved; treated as a research compound.
Dosing. P21 (Adamax) is typically dosed at 5-20 mg (intermittent). RG3 (Rhodiola) is typically dosed at 3-6 mg (daily).
Can you stack them?
Some protocols combine peptides, but stacking P21 (Adamax) and RG3 (Rhodiola) has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.
Frequently asked questions
- What is the difference between P21 (Adamax) and RG3 (Rhodiola)?
- P21 (Adamax) and RG3 (Rhodiola) are both cognitive enhancement peptides, but they differ in mechanism, dosing, and regulatory status. P21 (Adamax) is not FDA-approved; generally classified as a research compound, whereas RG3 (Rhodiola) is not FDA-approved; generally classified as a research compound.
- What is P21 (Adamax) used for?
- Neurogenic peptide.
- What is RG3 (Rhodiola) used for?
- Adaptogenic peptide.
- Can you take P21 (Adamax) and RG3 (Rhodiola) together?
- Some users combine peptides within a single protocol, but stacking P21 (Adamax) and RG3 (Rhodiola) has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
- Is P21 (Adamax) or RG3 (Rhodiola) FDA-approved?
- P21 (Adamax) is not FDA-approved; generally classified as a research compound. RG3 (Rhodiola) is not FDA-approved; generally classified as a research compound.
Read the full articles
- P21 (Adamax) — full monograph: mechanism, research, dosing & references
- RG3 (Rhodiola) — full monograph: mechanism, research, dosing & references